Bioceres Crop Solutions vs Mosaic
BIOX and MOS side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIOX and MOS compare
Mosaic grew revenue faster over the last twelve months (0.02% versus −17.7% for Bioceres Crop Solutions).
Mosaic pays a dividend yielding 3.9%; Bioceres Crop Solutions does not pay one.
Mosaic scores higher on the StockData Score (5 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIOX | MOS |
|---|---|---|
| Size and price | ||
| Market cap | – | $7.2B |
| Share price | $0.233 | $22.80 |
| Change, 1 year | −86.6% | −11.9% |
| Change, 5 years | −98.5% | −37.1% |
| Beta (5Y) | 0.76 | 0.81 |
| Employees | 562 | 13K |
| StockData Score | ||
| Total score | 1 | 5 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/S | – | 0.6× |
| P/B | – | 0.6× |
| EV/EBITDA | – | 22.3× |
| FCF yield | – | −11.2% |
| Growth | ||
| Revenue growth (TTM) | −17.7% | 0.02% (better) |
| Revenue growth, 5Y average | 2.6% | 6.8% (better) |
| Net income growth (TTM) | – | −191% |
| EPS growth (TTM) | – | −191% |
| EPS growth, 5Y average | – | −0.58% |
| Profitability | ||
| Gross margin | 34.9% (better) | 7.4% |
| Operating margin | −9.8% | −5.1% (better) |
| Net margin | – | −9.4% |
| FCF margin | 27.3% (better) | −6.8% |
| Return on equity | – | −9.3% |
| Return on invested capital | −7.4% | −2.9% (better) |
| Financial health | ||
| Debt / equity | 10.01 | 0.48 (better) |
| Net debt / EBITDA | – | 9.12 |
| Interest coverage | −0.6× | – |
| Current ratio | 0.80 | 1.50 (better) |
| Altman Z-score | – | 1.62 |
| Piotroski F-score | – | 8 |
| Dividends and buybacks | ||
| Dividend yield | – | 3.9% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 34.5% |
| Shareholder yield | – | 3.9% |
| Ownership | ||
| Held by institutions | 13.2% | 95.4% |
| Held by insiders | 73.3% | 0.31% |
| Insider net buying, 12 months | – | −$509K |
| Short interest, % of float | 2.7% | 11.8% |
Go deeper
- BIOX stock overview
- BIOX income statement
- BIOX valuation and score
- MOS stock overview
- MOS income statement
- MOS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.